Immunic
IMUX
21 hedge funds and large institutions have $13M invested in Immunic in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
5% more funds holding
Funds holding: 20 → 21 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.11% less ownership
Funds ownership: 2.11% → 2.01% (-0.11%)
37% less capital invested
Capital invested by funds: $20.7M → $13M (-$7.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$58.7K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$38.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$25.7K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$22.5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$20.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$12.7K |
| 2 |
Millennium Management
New York
|
-$9.65K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3K |
IMUX Hedge Fund Activity: Q1 2020 in Review
21 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q1 2020, worth a combined $13M — down 37% from $20.7M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IMUX positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $58.7K. The largest seller was BlackRock, cutting an estimated $12.7K.
- 21 institutional investors held Immunic (IMUX) as of Q1 2020, up from 20 in Q4 2019.
- Funds reported $13M of Immunic stock for Q1 2020, down 37% quarter-over-quarter.
- 3 funds opened new Immunic positions in Q1 2020 and 2 closed out, a net change of +1 holder.
- The largest Immunic buyer in Q1 2020 was Renaissance Technologies, an estimated $58.7K added.
- The largest Immunic seller in Q1 2020 was BlackRock, an estimated $12.7K sold.
Based on aggregated 13F filings for Q1 2020.